Marcel van der Brug is a experienced professional who co-founded Character Biosciences and currently holds positions in various companies like Stealth and Neuron23. With a background in biology and genetics, Marcel has been instrumental in leading preclinical and clinical strategies for developing therapies for inflammatory and neurodegenerative diseases.
September, 2022 - present
September, 2018
Co-Founder, Scientific Advisory Board Member at Aenitis Technologies
Co-founder & Scientific Advisory Board Member at Clarametyx Biosciences, Inc.
Co-Founder & Scientific Advisory Board Member at BiomeSense
Co-founder, Scientific Advisory Board Member at Aarvik Therapeutics
Co-Founder & Scientific Advisory Board Member at Kojin Therapeutics